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Abstract
Background: We have previously shown marked upregulation of the mRNA and corresponding protein for the cellular
motor molecule myosin VI (Myo6) after an extremely traumatic stress experience, along with a delayed decrease in 5-bromo-
29-deoxyuridine incorporation in the murine hippocampus, a brain structure believed to undergo adult neurogenesis. In this
study, we investigated the role of Myo6 in both proliferation and differentiation in pluripotent P19 cells by using stable
transfection and RNA interference techniques.
Methodology/Principal Findings: Stable overexpression of Myo6 not only led to significant inhibition of the reducing
activity of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) and the size of clustered aggregates in
P19 cells, but also resulted in selectively decreased mRNA expression of the repressor type proneural gene Hes5 without
affecting the expression of neuronal and astroglial marker proteins. In P19 cells transfected with Myo6 siRNA, by contrast, a
significant increase was found in the size of aggregate and MTT reduction along with increased Sox2 protein levels, in
addition to marked depletion of the endogenous Myo6 protein. In C6 glioma cells, however, introduction of Myo6 siRNA
induced a drastic decrease in endogenous Myo6 protein levels without significantly affecting MTT reduction. The Ca2+
ionophore A23187 drastically increased the luciferase activity in P19 cells transfected with a Myo6 promoter reporter
plasmid, but not in HEK293, Neuro2A and C6 glioma cells transfected with the same reporter.
Conclusions/Significance: These results suggest that Myo6 may play a predominant pivotal role in the mechanism
underlying proliferation without affecting differentiation to progeny lineages in pluripotent P19 cells.
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Introduction
We have previously shown significant alterations in endogenous
levels of both glutamic and gamma-aminobutyric acids in
particular brain structures after the extremely traumatic water
immersion restraint stress (WIRS) experience in rats [1]. In mice
with WIRS, a variety of long-lasting bidirectional behavioral
abnormalities similar to symptoms in patients with posttraumatic
stress disorder (PTSD) are seen even 14 days after the traumatic
stress, proceeded by marked and transient deterioration in
incorporation of the thymidine analog 5-bromo-29-deoxyuridine
(BrdU) in the dentate gyrus (DG) of the hippocampus [2].
The hippocampal DG has a unique ability to generate new
neurons throughout the entire life of an individual, often referred
to as adult neurogenesis [3,4]. The newly born cells develop into
granule neurons and are capable of extending axonal projections
to the CA3 area [5,6]. In our previous study, in fact, WIRS and
subsequent flashback experiences similarly lead to drastic but
transient decreases in the numbers of both neuronal and astroglial
cells derived from neural progenitors, with suppression of
proliferation in the DG in mice [7]. Moreover, the extremely
stressful experience induced a rapid but transient increase in the
expression of both the mRNA and corresponding protein for the
cellular motor molecule Myosin VI (Myo6) in the mouse
hippocampus [7].
Myosin VI (Myo6) is an actin-based molecule responsible for the
transport of intracellular cargos including proteins, vesicles and
organelles [8,9]. Myo6 has a unique property to move to the
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pointed (minus) ends of actin filaments, which is favorable for
orientation toward the cell center, whereas other native myosin
molecules are able to migrate toward the barbed (plus) ends of F-
actin [10]. This unique directionality allows Myo6 localized at the
plasma membrane to pull endocytic vesicles inward using the
migration force generated by its movement on F-actin [11]. In
addition, Myo6 exhibits a unique biological function through
several binding partners, such as disable-2 [12], G-Alpha
Interacting Protein (GAIP) C-terminus-interacting protein-1
[13,14], synapse-associated protein-97 [15] and RNA polymerase
II [16].
These previous studies led us to propose a possible role of Myo6
in mechanisms underlying the aforementioned suppression of
BrdU incorporation into the hippocampal DG enriched with
neural progenitor cells, in mice with traumatic stress. Therefore,
the present series of experiments was intended to examine the role
of Myo6 in mediating proliferation for self-replication and
differentiation into progeny lineages using murine embryonal
carcinoma P19 cells endowed to proliferate and differentiate into
neuronal and astroglial lineages in the presence of all-trans retinoic
acid (ATRA) as a model for neural progenitor cells [17].
Materials and Methods
P19 Cell Culture
Mouse embryonal carcinoma P19 cells (ATCC, Manassas, VA,
USA) were cultured in alpha minimal essential medium (aMEM)
(GIBCO BRL, Grand Island, NY, USA) supplemented with 10%
fetal bovine serum (FBS) (GIBCO BRL). P19 cells are able to
differentiate into a neural lineage in the presence of ATRA
(Sigma, St. Louis, MO, USA) as described previously [18].
Undifferentiated P19 cells were routinely sub-cultured at least
three times at intervals of 2 days prior to the treatment with
ATRA. P19 cells were then cultured in bacterial-grade Petri dishes
in the presence of 0.5 mM ATRA for 4 days under floating
conditions, trypsinized for dispersion, and plated onto tissue
culture-grade dishes coated with poly-L-lysine (Sigma) for induc-
tion of spontaneous differentiation during culture in the absence of
ATRA for 12 days under adherent conditions. The cultures were
always maintained in a humidified atmosphere of 5% CO2 and
95% air at 37uC with a medium change every 2 days.
Establishment of Stable Transfectants
The full-length coding region of porcine Myo6, which was
kindly donated by Dr. Tama Hasson (UCSD, San Diego, CA,
USA), was inserted into pSI vector using the Ligation High
reagent as described previously [19]. Mouse embryonal carcinoma
P19 cells were plated at a density of 1.56105 cells/cm2, followed
by culture in Dulbecco’s modified Eagle’s medium (DMEM)
(GIBCO BRL) with 10% FBS for 24 h and subsequent stable
transfection with pSI-Myo6, pSI-GFP and pcDNA3.1 vectors, or
pSI, pSI-GFP and pcDNA3.1 vectors, using 2 mg of DNA and
Lipofectamine and Plus reagent (Invitrogen, San Diego, CA, USA)
in 0.5 ml of Opti-MEM (Invitrogen) as described previously [20].
After 24 h, and every 48 h thereafter for 2 weeks, the culture
medium was replaced with fresh medium containing 500 mg/ml of
G418 (Invitrogen). Pools of 6 clones were isolated as stable
transfectants with either the Myo6 expression vector or empty
vector (EV) in P19 cells for further studies using clones between
passages of 3 and 6 [21]. BLAST database (http://blast.ncbi.nlm.
nih.gov) analysis revealed a 96% homology between porcine and
murine Myo6 proteins.
Determination of mRNA and Protein Expression
Reverse transcription-polymerase chain reaction (RT-PCR)
analysis was conducted as described previously [22]. Quantifica-
tion of PCR products was done by real time-based RT-PCR using
an Mx3005P (Agilent Technologies, Santa Clara, CA, USA) with
Table 1. Primers used in this study.
Genes Upstream (59-39) Downstream (59-39)
Cyclins
CyclinA1 AGCGACAGCTACTGAGGATGG CAGCAACCAAGGAAGGAAGATAC
CyclinA2 GGTGCTGCCAACTGTCAAGAT AAGTCAGCAGTTTGGTTTGGTTG
CyclinD1 AGTGCGTGCAGAAGGAGATT CACAACTTCTCGGCAGTCAA
bHLH transcriptional factor
Hes1 CCAGCCAGTGTCAACACGA AATGCCGGGAGCTATCTTTCT
Hes3 GATACGGAAACGAAAGCTGGA GAGGCAAGGGTTGAGAACAGA
Hes5 AGTCCCAAGGAGAAAAACCGA GCTGTGTTTCAGGTAGCTGAC
Mash1 GCAACCGGGTCAAGTTGGT GTGGTTGGAGTAGTTGGGGG
Math1 CAACGACAAGAAGCTGTCCA CCTAACTGGCCTCGTCAGAG
Math3 AGGCCAATGCTAGAGAACGA ATGGTTGAGGCTTGAGATGG
NeuroD1 ATGACCAAATCATACAGCGAGAG TCTGCCTCGTGTTCCTCGT
Ngn1 CAGTAGTCCCTCGGCTTCAG GGGTCAGTTCTGAGCCAGTC
Pluripotentiality marker
???? AGAGGATCACCTTGGGGTACA CGAAGCGACAGATGGTGGTC
Nanog CACAGTTTGCCTAGTTCTGAGG GCAAGAATAGTTCTCGGGATGAA
Others
Myo6 CGCAGAACTACGCGATACAA CCTTGCCAGCTACAAGAAGG
Gapdh ACCACAGTCCATGCCATCAC TCCACCACCCTGTTGCTGTA
doi:10.1371/journal.pone.0063947.t001
Myosin VI in Neurogenesis
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a THUNDERBIRD SYBR qPCR Mix (TOYOBO, Osaka,
Japan). The relative amount of each transcript was normalized
against glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
[23]. The primer sequences used are summarized in Table 1.
Western blotting was done by using antibodies against Myo6
(Santa Cruz Biotechnology, Santa Cruz, CA, USA), Doublecortin
(Cell Signaling Technology, Danvers, MA, USA), Synapsin I
(Merck Ltd., Darmstadt, Germany), neuronal nuclei (NeuN)
(Merck Ltd.), microtubules-associated protein-2 (MAP2) (Sigma),
Figure 1. Stable overexpression of Myo6. (A) Mouse embryonal P19 cells were stably transfected with Myo6 expression vector, followed by
selection by G418 and subsequent determination of Myo6 mRNA expression with RT-PCR analysis. Several clones of stable transfectants were
cultured with ATRA for 4 days for subsequent (B) micrographic observation and (C) MTT reduction determination. Each value represents the mean 6
S.E. in 4 different experiments. *P,0.05, **P,0.01, significantly different from the control value in stable EV transfectants.
doi:10.1371/journal.pone.0063947.g001
Figure 2. Cellular viability in stable transfectants of P19 cells. Several clones of stable transfectants were cultured with ATRA for 4 days,
followed by determination of (A) the percentage of PI-positive cells over Hoechst33342-positive cells and (B) the activity of LDH released into culture
medium. Each value represents the mean 6 S.E. in 4 different experiments.
doi:10.1371/journal.pone.0063947.g002
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glial fibrillary acidic protein (GFAP) (Sigma), Sox2 (Santa Cruz
Biotechnology) and b-tubulin (Sigma) as described previously [22].
Determination of Cellular Proliferation
Five different visual fields each in parallel experiments were
chosen at random from each culture well with undifferentiated
P19 cells cultured with ATRA for a period of up to 4 days, and
examined under a phase contrast micrograph in a blinded fashion,
followed by calculation of areas of round aggregates composed of
clustered proliferating cells for summation using Scion Image b
4.02 software (Scion Co., Frederick, MD, USA) as described
previously [22]. Moreover, cultured cells collected by centrifuga-
tion at 300 g were incubated with 0.5 mg/ml 3-(4,5-dimethyl-2-
thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) (Sigma) in
phosphate-buffered saline (PBS) for 1 h at 37uC, followed by
addition of 0.04 M HCl in isopropanol and subsequent shaking of
the mixture for 10 min to dissolve the formazan. The dissolved
suspension was scanned by an ELISA reader for measurement of
the absorbance at a wavelength of 550 nm as described previously
[24].
Determination of Cellular Viability
Stable transfectant cells were cultured in the presence of ATRA
for 4 days, followed by re-plating on dishes previously coated with
poly-L-lysine for further culture for 2 h and subsequent double
staining for DNA with 10 mg/ml Hoechst33342 (Sigma) and 5 mg/
ml propidium iodide (PI) (Sigma). Cells were observed under a
confocal microscope (LSM-510; Carl Zeiss, Jena, Germany). The
number of cells stained with these dyes was individually counted in
five different visual fields selected at random in a blinded fashion
in order to calculate the percentages of dead cells stained with the
membrane-impermeable dye PI out of the total cells stained with
the membrane-permeable dye Hoechst33342. Cellular viability
was also quantified by the activity of lactate dehydrogenase (LDH)
released into the culture medium by an enzyme-coupled color
development method as descried previously [25] with minor
modifications [22].
Determination of Cellular Differentiation
Pluripotent P19 cells have been shown to differentiate into
neuronal and astroglial lineages after commitment in the presence
of ATRA as described previously [17]. Undifferentiated P19 cells
were plated onto 0.2% agarose coated dishes (w100 mm) at a
density of 16105 cells/ml in aMEM supplemented with 5% FBS
and 0.5 mM ATRA, followed by culture for 4 days under floating
conditions favorable for proliferation. These floating cells were
harvested and trypsinized, followed by plating onto dishes
previously coated with poly-L-lysine at a density of 26105 cells/
ml in aMEM supplemented with 10% FBS. They were
subsequently cultured for an additional period up to 6 days in
the absence of ATRA to induce spontaneous differentiation as
shown with murine fetal cortical progenitors [22]. The culture
medium was changed every 2 days, and cultures were maintained
in a humidified atmosphere of 5% CO2/95% air at 37uC.
Preparation of Reporter Plasmids
A reporter plasmid with the Myo6 promoter was prepared as
follows. The mouse Myo6 promoter was obtained by cloning using
the forward primer 59-ACGCGT (MluI site) GCAAGAACCCT-
CACTGGC-39 and the reverse primer 59-CTCGAG (XhoI site)
AGGCTGCCGGGCTGCGGGCG-39 from the mouse genome.
The Myo6 (-1086 to+210) promoter fragment was cloned into the
promoterless pGL-3 basic vector (Promega, Madison, WI, USA),
to create the recombinant plasmid –1086/+210 Myo6-Luc.
Reporter Assay
Pluripotent P19 cells were transiently transfected with a reporter
plasmid containing the promoter region of Myo6 (21086 bp to
Figure 3. Expression of cell cycle regulator mRNA and progenitor marker protein in stable transfectants. Stable transfectants were
cultured with ATRA for 4 days, followed by determination of expression of (A,B) mRNA with RT-PCR and (C) protein with Western blotting.
Quantitative data are shown as the mean 6 S.E. in 3 different experiments.
doi:10.1371/journal.pone.0063947.g003
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+210 bp) along with the internal control vector pRL-SV40
(Promega) using the Lipofectamine 2000 reagent. Transfected
cells were plated at 16105 cells/ml in plates (w100 mm) previously
coated with 0.2% agarose, and cultured in aMEM supplemented
with 10% FBS and 0.5 mM ATRA. Twenty-four hours after
transfection of the reporter plasmid, the cells were exposed to
1 mM A23187 (Sigma) for 6 h, followed by a medium change, and
then cultured for an additional 24 or 48 h. The cells were then
lysed for determination of luciferase activity using specific
substrates in a luminometer according to the manufacturer’s
protocol. Transfection efficiency was normalized against the
activity of pure Renilla luciferase [22]. Approximately 30% of
cells expressed green fluorescent protein (GFP) in P19 cells
transfected with the EGFP-C2 plasmid under the transfection
conditions employed.
Data Analysis
Quantitative data are expressed as the mean 6 S.E. and the
statistical significance was determined by the two-tailed Student’s
t-test or one-way analysis of variance (ANOVA) with the
Bonferroni/Dunnett post hoc test.
Results
Stable Transfection of Myo6
In our previous study [26], transient overexpression of Myo6 led
to a decrease in the size of clustered aggregates composed of
proliferating cells during culture with ATRA in pluripotent P19
cells. Amongst 6 clones selected by G418 screening in pluripotent
P19 transfectants, Myo6 mRNA was strongly detected in several
clones, such as M6#1 and M6#4, upon RT-PCR analysis
(Figure 1A). These transfectants were invariably clustered, forming
round aggregates while continuing to grow in size up to 4 days
during culture under floating conditions in the presence of ATRA,
along with increased proliferation. However, stable Myo6
transfection led to a marked decrease in the size of clustered
aggregates formed after culturing with ATRA for 4 days
(Figure 1B). In both stable Myo6 transfectant clones, in fact, a
significant deterioration was seen in MTT reducing activity
compared to that in stable EV transfectants after 4 days in culture
(Figure 1C). In both stable Myo6 transfectants, after 4 days, no
significant changes were detected in the percentages of dead cells
stained with PI out of the total cells stained with Hoechst33342
(Figure 2A) or the release of LDH into the culture medium
(Figure 2B) compared with stable EV transfectants.
Expression of Proliferation-relevant Markers
To evaluate the mechanism underlying the possible deteriora-
tion in proliferative activity, each stable transfectant clone was
screened for mRNAs for several cell cycle regulators of the Cyclin
family [27]. However, no marked alteration was found in mRNA
expression of CyclinA1, CyclinA2 or CyclinD1 between stable
Myo6 and EV transfectants (Figure 3A). Densitometric quantifi-
cation of these data confirmed the absence of significant changes
in the mRNA expression of these cyclins in the stable Myo6
transfectants examined (Figure 3B), in contrast to the suppressed
Figure 4. Expression of mRNA for bHLH proneural transcription factors and pluripotentiality markers in stable transfectants. Stable
transfectant cells were cultured with ATRA for 4 days, followed by determination of mRNA expression levels with real time-based RT-PCR. *P,0.05,
**P,0.01, significantly different from each control value in stable EV transfectants.
doi:10.1371/journal.pone.0063947.g004
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proliferation seen after Myo6 overexpression. We then examined
expression of the progenitor marker protein Sox2 in stable Myo6
transfectants cultured for 4 days in the presence of ATRA under
floating conditions. In both stable Myo6 transfectant clones,
despite having lower MTT reduction activity than control clones,
a marked decrease was seen in the endogenous Sox2 protein level
(Figure 3C).
An attempt was thus made to determine whether stable
overexpression of Myo6 leads to altered expression of a variety
of basic helix-loop-helix (bHLH) genes responsible for the positive
and negative regulation of proliferation for self-renewal and/or
neuronal differentiation in undifferentiated neural stem cells [28].
We examined quantitative expression profiles of both activator
[Mash1, Math1, Math3, NeuroD1 and Neurogenin1 (Ngn1)] and
repressor [hairy and enhancer of split-1 (Hes1), Hes3 and Hes5]
classes of bHLH proneural genes, in addition to pluripotentiality
markers such as Oct4 and Nanog, via real time RT-PCR. In
undifferentiated clones of stable Myo6 transfectants, among the
different genes tested, statistically significant downregulation was
only found in Hes5 mRNA compared to that in stable control
transfectants (Figure 4).
Marker Protein Expression
P19 cells were cultured in the presence of ATRA for 4 days
under floating conditions to induce clustered aggregate formation
due to self-replication, followed by immunostaining for the neural
progenitor cell marker nestin. Cells clustered in round aggregates
were immunoreactive for nestin and also exhibited a marked
increase in MTT reduction, both indices of cellular proliferation
[26]. The aggregated cells were then dispersed and cultured
further in the absence of ATRA for an additional 12 days under
adherent conditions. Four days after replating, the cells were
observed to express neuronal marker proteins such as MAP2 and
NeuN at high levels without expressing the astroglial marker
protein GFAP, followed by disappearance of MAP2-positive cells
and subsequent appearance of cells immunoreactive for GFAP 8
to 12 days after re-plating (Figure 5A). By contrast, levels of the
other neuronal marker Synapsin 1 were highest on Day 8 with
progressively lower expression on Day 12, Day 14 and Day 16
during their 16 days in culture. Moreover, the migrating neuronal
progenitor marker Doublecortin was strongly expressed by cells
cultured for 8 days, whereas the progenitor marker Sox2 was
expressed in cells throughout the 16 days in culture. Similar
expression profiles were seen for immunoreactive MAP2 and
GFAP in stable EV transfectants during the 16 days, while no
significant difference was found in the temporal expression profile
of either MAP2 (Figure 5B, upper panel) or GFAP (Figure 5B,
lower panel) in the stable Myo6 transfectants M6#1 and M6#4
compared to those cells with EV.
Knockdown of Myo6 Expression with siRNA
We next examined the effects of Myo6 knockdown on
proliferation and differentiation of pluripotent P19 cells using
RNA interference techniques. Cells were transfected with Myo6
Figure 5. Expression of several marker proteins in stable transfectants. (A) Pluripotent P19 cells were cultured with ATRA for 4 days under
floating conditions, followed by dispersion of clustered aggregates and subsequent further culture in the absence of ATRA for an additional 12 days
under adherent conditions. Cells were harvested different days during culture for determination of several marker protein expression with Western
blotting analysis. (A) Typical pictures are shown with similar results in 3 separate determinations. (B) Stable transfectants were cultured for a period of
up to 16 days as described above, followed by quantitative determination of MAP2 and GFAP on Western blotting. Each value represents the mean6
S.E. in 4 different experiments.
doi:10.1371/journal.pone.0063947.g005
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siRNA, followed by culture with ATRA for 2 days under floating
conditions and subsequent determination of endogenous levels of
Myo6. A drastic decrease in endogenous Myo6 protein levels in
cells transfected with 2 different Myo6 siRNA oligonucleotides
compared with those with a control oligonucleotide was invariably
seen on Western blotting (Figure 6A). Quantification analysis
confirmed a significant decrease in Myo6 protein levels in P19 cells
treated with Myo6 siRNA (Figure 6B). In the cells with decreased
endogenous Myo6 levels, a statistically significant increase was
found in the sizes of the clustered aggregates composed of
proliferating cells (Figure 6C) (Figure 6D). Similarly, both Myo6
siRNA oligonucleotides were effective in significantly increasing
MTT reduction in P19 cells cultured for 2 days (Figure 6E).
We then examined the expression of Sox2 in P19 cells treated
with Myo6 siRNA for 2 or 4 days in the presence of ATRA under
floating conditions. Western blotting analysis clearly revealed a
marked, statistically significant increase in endogenous Sox2
protein levels in P19 cells transfected with Myo6 siRNA for 2
and 4 days compared to those exposed to control siRNA
(Figure 7A) (Figure 7B). Cells were next transfected with Myo6
siRNA for 4 days with ATRA, followed by dispersion of the
aggregates and further culturing in the absence of ATRA for an
additional 2 days under adherent conditions to promote sponta-
neous differentiation. A marked increase was invariably seen in
endogenous levels of several neuronal marker proteins, including
Doublecortin, MAP2, Synapsin 1 and NeuN, in P19 cells after the
removal of ATRA and subsequent additional culture, irrespective
of transfection with Myo6 siRNA, while Myo6 knockdown failed
to significantly affect endogenous levels of these neuronal marker
proteins during culture for an additional 2 days (Figure 7C).
Cell Selectivity
To test the selectivity of the correlation between Myo6
expression and cellular proliferation, the MTT assay was used to
determine whether Myo6 siRNA affects cellular proliferation in
cultured proliferating cells other than pluripotent P19 cells. In C6
glioma cells cultured for 2 days, marked expression of Myo6
protein was seen in a manner sensitive to knockdown by siRNA
(Figure 8A). Although MTT reduction gradually increased in C6
glioma cells treated with control siRNA during increasing culture
periods up to 4 days, Myo6 siRNA failed to significantly affect
MTT reduction during the 4 days (Figure 8B). In the neuronal cell
line Neuro2A, moreover, Myo6 protein was not highly expressed
irrespective of transfection with Myo6 siRNA (Figure 8C).
Furthermore, Myo6 siRNA again failed to significantly modulate
MTT reduction in Neuro2A cells cultured for 4 days (Figure 8D).
We have previously shown a more than twofold increase in
Myo6 mRNA expression is induced in P19 cells exposed to the
calcium ionophore A23187 [26]. In fact, in P19 cells bearing a
luciferase reporter plasmid linked to the Myo6 promoter region
(21086 to +210 bp), 1 mM A23187 drastically increased luciferase
activity determined 48 h after transfection with the reporter
Figure 6. Knockdown of Myo6 protein expression with siRNA in P19 cells. P19 cells were transfected with Myo6 siRNA in the presence of
ATRA for 2 days, followed by determination of endogenous levels of Myo6 protein on Western blotting. Typical pictures are shown in the panel (A),
while quantitative data are shown in the panel (B). Cells were also subjected to (C) phase contrast micrographic observation, (D) aggregate size
measurement and (E) MTT reduction determination. Each value represents the mean 6 S.E. in 3–4 different experiments. *P,0.05, **P,0.01,
significantly different from each control value obtained in cells transfected with siControl.
doi:10.1371/journal.pone.0063947.g006
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plasmid (Figure 9A). By contrast, A23187 was ineffective in
significantly increasing luciferase activity in C6 glioma, Neuro2A
and HEK293 cells transfected with the reporter plasmid at 1 mM
when determined 24 and 48 h after transfection (Figure 9B).
Discussion
The essential importance of the present findings is that
proliferation was markedly suppressed in pluripotent P19 cells
stably overexpressing the motor protein Myo6 without induction
of cell death. Conversely, the current findings that proliferation
was significantly promoted in P19 cells by decreased endogenous
Myo6 levels due to siRNA transfectionargue in favor of the idea
that Myo6 negatively regulates self-replication in pluripotent P19
cells endowed to either proliferate for self-renewal or differentiate
into neuronal and astroglial lineages. Taking into consideration
the unresponsiveness of different cell cycle regulators and bHLH
proneural genes other than Hes5, it is conceivable that downreg-
ulation of Hes5 expression is at least in part responsible for the
inhibition of proliferation in stable Myo6 transfectants. In mice
defective for the activator bHLH factor Mash1, for example,
severe loss of neuronal precursors together with disappearance of
the Notch signaling target Hes5 is seen in the ventral telenceph-
alon normally enriched for Mash1 during neurogenesis [29].
Notch signaling is shown to mediate a cell-cell interaction required
for the maintenance of actively dividing cells and subsequent
generation of different progeny cell lineages in a manner
dependent on expression of the repressor type bHLH genes
Hes1 and Hes5, whichantagonize activator type neuronal bHLH
genes such as Mash1 [30]. By contrast, both Hes1 and Hes5 are
essential Notch effectors in negatively regulating mammalian
neuronal differentiation [31].
However, the reason why Myo6 overexpression inhibited
cellular proliferation without affecting the mRNA levels of several
cyclins in P19 cells is still not clear. A future comprehensive
analysis should be conducted on mRNA expression by all cyclin
family members and relevant kinases to evaluatethe possible
involvement of particular cyclin family members in the underlying
mechanisms other than those tested here. Although the activator
type bHLH factor NeuroD1 plays a pivotal role in the survival and
neuronal differentiation of neural stem cells during adult
neurogenesis [32,33], NeuroD1 is also identified as a gene highly
correlated with the terminal differentiation into neurons during
postnatal and adult neurogenesis on microarray gene analysis [34].
To our knowledge, this is the first direct demonstration of
predominant inhibition of proliferation without affecting commit-
ment and/or differentiation into progeny lineages through a
mechanism relevant to downregulation of the repressor bHLH
Figure 7. Expression of several marker proteins in P19 cells with Myo6 siRNA. (A) Pluripotent P19 cells were transfected with Myo6 siRNA in
the presence of ATRA for 2 or 4 days under floating conditions, followed by determination of Sox2 protein expression with Western blotting analysis.
Typical pictures are shown in the panel (A), while quantitative data are shown in the panel (B) for cells cultured for 4 days. (C) Cell aggregates were
also dispersed and further cultured in the absence of ATRA for an additional 2 days under adherent conditions for determination of several marker
protein expression with Western blotting analysis. Each value represents the mean 6 S.E. in 3 different experiments. *P,0.05, **P,0.01, significantly
different from each control value obtained in cells transfected with siControl.
doi:10.1371/journal.pone.0063947.g007
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proneural gene Hes5 in undifferentiated pluripotent P19 cells with
stable Myo6 overexpression.
Nevertheless, the exact signaling pathway from stable overex-
pression of Myo6 to preferential downregulation of Hes5 amongst
different repressor and activator bHLH proneural genes examined
is not clarified so far. One possible but hitherto unproven
speculation is that intracellular Myo6 overexpression promotes
the migration of particular cargo proteins and/or organelles
required to suppress the transactivation of the Hes5 gene toward
the nucleus. For instance, the mammalian target of rapamycin
(mTOR) signals are known to be essential for maintenance of
neural progenitor status through a mechanism associated with
upregulation of Hes5 and Pax6 expression in pluripotent P19 cells
cultured with ATRA [35]. The prevailing view is that activation of
the mTOR signaling pathway is required for protein translation,
cell growth and deteriorated autophagy toward the facilitation of
cell growth and proliferation [36]. These previous findings all gave
rise to an idea that stable overexpression of Myo6 would lead to
negative regulation of the mTOR signaling pathway responsible
for subsequent promotion of gene transactivation of particular
activator and repressor bHLH factors in neural progenitors. The
reason why downregulation of Hes5 expression failed to affect
subsequent differentiation fates in pluripotent P19 cells, however,
is not clear. A future analysis of overexpression and knockdown of
Hes5 in P19 cells will undoubtedly give a clue to this question.
In hippocampal neurons from sv/sv mice defective for Myo6, a
significant deficit is seen in internalization of a particular
ionotropic subtype of non-N-methyl-D-aspartate receptor
(NMDAR) after stimulation [37]. Both Myo6 and its binding
protein are required for glutamate release mediated by the
interaction of brain-derived neurotrophic factor with TrkB
receptors [38]. In addition to the selective and rapid expression
of Myo6 in response to an acute traumatic stressful experience [7],
flashbacks to virtual re-experience have been demonstrated to
induce Myo6 protein expression in the murine hippocampus [26].
Synaptic abnormalities occur along with short dendritic spines and
marked astrogliosis in the hippocampus of Myo6-null mice, while
profound synaptic loss is seen in cultured hippocampal neurons
with dominant-negative disruption of Myo6, in addition to those
prepared from Myo6-deficient mice [37]. These previous findings
clearly give support to the importance of Myo6 in molecular
mechanisms underlying synaptogenesis in the hippocampus. The
possibility that abnormally overexpressed Myo6 could lead to a
variety of hippocampal dysfunctions seen after a traumatic stress
experience, which would at least in part relate to the pathogenesis
of PTSD in human beings [39], is not ruled out.
Although Myo6 is highly expressed in cultured astrocytes
expressing GFAP rather than in cultured neurons expressing
NeuN [26], a previous study showed localization of Myo6 to
neurons in association with postsynaptic density [37]. However,
immunoreactive Myo6 expression is not localized in particular
Figure 8. Myo6 protein expression in C6 glioma and Neuro2A cells with siRNA. C6 glioma and Neuro2A cells were transfected with Myo6
siRNA, followed by culture for 2 days under individually appropriate conditions and subsequent determination of endogenous levels of Myo6 protein
on Western blotting. Cells were also cultured for different periods up to 4 days toward determination of MTT reduction. Typical pictures are shown
with Myo6 expression by C6 glioma cells in the panel (A) and that by Neuro2A in the panel (C), while quantitative data are shown with MTT reduction
by C6 glioma cells in the panel (B) and that by Neuro2A cells in the panel (D), respectively. Each value represents the mean 6 S.E. in 3 different
experiments.
doi:10.1371/journal.pone.0063947.g008
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neuronal layers within the cerebral cortex, striatum, hippocampus
or olfactory bulb in the mouse brain [7]. The inconsistent
distribution profiles between Myo6 and GFAP in discrete brain
regions, along with temporal expression profiles in pluripotent P19
cells [26], do not argue in favor of the possible predominance of
Myo6 expression in certain types of cells in the brain. In fact,
Myo6 was originally demonstrated to be responsible for clathrin-
mediated endocytosis and vesicular trafficking in non-neuronal
cells [11,40]. The fact that activation of NMDAR leads to a
significant increase in Myo6 mRNA expression in pluripotent P19
cells expressing functional NMDAR channels [26] gives support to
an idea that traumatic stress induces glutamate release [41,42] for
suppression of self-replication through induction of Myo6 in
response to activation of NMDAR expressed by neural progenitor
cells in the adult mouse DG. Indeed, prior blockade of NMDAR
by dizocilpine prevents decreased incorporation of BrdU into the
DG as well as behavioral abnormalities in mice exposed to WIRS
[2].
Conclusion
It thus appears that the motor protein Myo6 selectively inhibits
cellular proliferation required for self-replication through a
mechanism relevant to downregulation of the repressor bHLH
proneural factor Hes5 in undifferentiated P19 cells. Further
evaluation of Myo6 expression will be undoubtedly beneficial for
the future discovery and development of drugs useful for the
prophylaxis, therapy and treatment of a variety of abnormalities
and malfunctions seen in patients suffering from different
neurodegenerative and neuropsychiatric diseases.
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